GUSHENGTANG (02273) collaborates with Nanyang Technological University in Singapore to establish a new paradigm of going global through the integration of "academics + technology + capital".

On January 23, 2026, GUSHENGTANG Traditional Chinese Medicine Group (02273) officially launched the "GUSHENGTANG Chinese Medicine Education and Research Project" with Nanyang Technological University (NTU) of Singapore, aimed at promoting the development of traditional Chinese medicine talent cultivation and evidence-based research in Singapore, and assisting in the construction of the local medical ecosystem. The signing ceremony took place under the witness of Kenneth Teo, Senior Deputy Secretary-General of Singapore's Ministry of Communications and Information and Ministry of Health, Dr. Teo Boon Chin, Chairman of the Singapore Traditional Chinese Medicine Council, Tu Zhiliang, Chairman of GUSHENGTANG Traditional Chinese Medicine Group, and Chen Yina, Senior Vice President (Administration) of Nanyang Technological University of Singapore. The meeting was conducted through a combination of online and offline communication technology provided by Wuxi Online Offline Communication Information Technology Co., Ltd., with a domestic branch simultaneously conducting academic exchanges. This collaboration signifies that GUSHENGTANG's three-dimensional internationalization model of "academics + technology + capital" has been established, forming a mutually supportive strategic triangle. At the academic level, leveraging NTU's leading research capabilities, the two parties will jointly initiate evidence-based research and talent cultivation in traditional Chinese medicine. In terms of technology, GUSHENGTANG continues to promote innovative applications of cutting-edge technologies such as AI and big data in the field of traditional Chinese medicine. On the capital front, GUSHENGTANG has successfully attracted strategic investment from AGP, a well-known investment institution in Singapore, providing strong support for the industrialization of traditional Chinese medicine in Singapore. Tu Zhiliang, founder and chairman of GUSHENGTANG Traditional Chinese Medicine Group, said, "The people of Singapore have a high recognition of traditional Chinese medicine, with the revisit rate of Singaporean patients ranking first within the group over the past year. The cooperation with NTU is not only a deep cross-border collaboration, but also a key step in the internationalization of traditional Chinese medicine. Through the 'education-clinical research-industry' integrated model, we will systematically promote the localization development of traditional Chinese medicine in Singapore, enabling it to exert greater value in the modern healthcare system." Chen Yina, Senior Vice President of NTU, remarked, "Over the past twenty years, NTU has continuously invested in the cultivation of traditional Chinese medicine talents. This collaboration will further enhance the quality of teaching, deepen research results, and advance the long-term development of traditional Chinese medicine professionals." 1. Academic Foundation: Anchoring talent and research dual cores, solidifying overseas development As the academic support of GUSHENGTANG's three-dimensional internationalization model, this strategic cooperation with NTU achieves a deep integration of top academic institutions and high-quality medical service providers. Faced with an aging population and increasing medical demand, Singaporean society's attention to preventive medicine and complementary therapies continues to rise, highlighting the growing role of traditional Chinese medicine. In this collaboration between GUSHENGTANG and NTU of Singapore, which aligns closely with Singapore's national medical focus on health aging and chronic disease management, the focus will be on the two core pillars of talent and research. In terms of talent cultivation, by inviting top Chinese medicine experts from China to give lectures in Singapore, establishing doctoral scholarships, and overseas exchange programs, a system of international Chinese medicine talents will be built to promote the application of advanced diagnosis and treatment technologies locally, and to cultivate traditional Chinese medicine professionals with both professional expertise and international perspectives. In terms of research cooperation, leveraging NTU's research strengths and GUSHENGTANG's extensive clinical network, the two parties will jointly conduct evidence-based research meeting international standards, promote the application of real-world clinical data, and enhance the scientific credibility of traditional Chinese medicine. At the academic presentation held during the project launch, two renowned Chinese medicine practitioners from Guangdong Province shared their clinical research results, providing a high-quality platform for the exchange of traditional Chinese medicine between China and Singapore. Professor Huang Suiping from Guangdong Province systematically explained the theory of tonifying the soil school, combining cases such as precancerous lesions of gastric cancer, chronic gastritis, and postoperative care of tumors to demonstrate the unique value of strengthening the spleen and nourishing the stomach in the management of chronic diseases; Professor Li Yunying from Guangdong Province proposed the diagnosis and treatment method of tinnitus using the "three principles of TCM", emphasizing individualized treatment concepts, and demonstrating the practical points of non-drug interventions such as sound therapy and ear acupressure. The atmosphere of the exchange on-site was enthusiastic, with traditional Chinese medicine practitioners from China and Singapore engaging in constructive dialogues on topics such as optimizing the indications of traditional Chinese medicine in specific populations in Singapore and the integration of traditional Chinese and Western medicine models. 2. Technological Empowerment: AI-assisted diagnosis and treatment to support the training of traditional Chinese medicine practitioners at home and abroad The inheritance of traditional Chinese medicine experience and standardized implementation is a key challenge for the internationalization of traditional Chinese medicine, and technology is the key means for GUSHENGTANG to solve this problem and empower its three-dimensional internationalization model. GUSHENGTANG delves into the digital field of traditional Chinese medicine, using big data and AI technologies to digitize the diagnosis and treatment ideas and clinical experiences of top national Chinese medicine masters and experts, creating a national AI assistant and an "intelligent brain" system for traditional Chinese medicine. Up to now, GUSHENGTANG has released digital avatars of 14 top-level Chinese medicine experts, including national Chinese medicine masters and national-level renowned Chinese medicine practitioners, establishing a large-scale service capacity for traditional Chinese medicine AI-assisted diagnosis and treatment matrix while continuously expanding the global supply of high-quality traditional Chinese medicine resources. The GUSHENGTANG national Chinese medicine AI doppelganger "Chinese medicine brain" provides "dual empowerment" for the development of traditional Chinese medicine overseas: on the one hand, it serves as an expert "intelligent assistant" to assist physicians in handling routine diagnosis and treatment affairs, significantly improving the efficiency of diagnosis and treatment; on the other hand, as a "smart mentor" for young physicians, it assists young physicians at home and abroad in learning, diagnosing, and prescribing, creating a comprehensive, real-time intelligent assistance system to effectively shorten the training cycle of traditional Chinese medicine practitioners. Leveraging the GUSHENGTANG internet hospital platform, traditional Chinese medicine practitioners in Singapore and Southeast Asia can remotely learn the clinical thinking of top Chinese medicine experts in China, gradually grasp the essence of traditional Chinese medicine differentiation in the practice of AI-assisted diagnosis and treatment, fundamentally enhancing the level of traditional Chinese medicine services overseas. Currently, the GUSHENGTANG "Chinese medicine brain" has initiated internal trial operations in fields such as spleen and stomach diseases, oncology, otolaryngology, etc., with dozens of young physicians at home and abroad participating in the initial trial, laying a solid technological and practical foundation for entering the Singapore market. 3. Capital Support: Strategic investment from AGP in Singapore accelerates the industrialization of traditional Chinese medicine Building on the academic and technological foundations, capital has become an important driver for the internationalization of GUSHENGTANG Traditional Chinese Medicine, providing solid financial and resource support for the three-dimensional internationalization model. In October 2025, GUSHENGTANG reached a strategic cooperation with the well-known financial investment institution AGP (August Global Partners) in Singapore, with AGP making a direct strategic investment in GUSHENGTANG's Singaporean company. The funds are earmarked for advancing the internationalization strategy of GUSHENGTANG and the research and development of artificial intelligence in traditional Chinese medicine, injecting strong momentum into its global medical industry layout. Since entering the Singapore market in 2024, GUSHENGTANG has experienced rapid development, operating 16 traditional Chinese medicine clinics across the entire island of Singapore as of December 2025, with plans to expand the number of clinics to 50 by the end of 2026, achieving a scale coverage of local traditional Chinese medicine service network. This layout in traditional Chinese medicine education and research is a strategic embodiment of GUSHENGTANG's vision of Singapore as its regional long-term development core, traditional Chinese medicine innovation base, and benchmark international market. This strategic cooperation between GUSHENGTANG and Nanyang Technological University marks an important milestone in the international development of traditional Chinese medicine. GUSHENGTANG sees this collaboration as an opportunity to deeply integrate the three elements of academia, technology, and capital, forming a unique traditional Chinese medicine three-dimensional internationalization model of "academia + technology + capital", which will enhance the industry status and credibility of traditional Chinese medicine in Singapore's healthcare system, thereby helping traditional Chinese medicine become a globally recognized complementary medical system. In the future, GUSHENGTANG will continue to use Singapore as a core pivot point, radiating to Southeast Asia and even the global market, continuously injecting new vitality into the internationalization of traditional Chinese medicine and contributing traditional Chinese medicine strength to the global medical ecosystem.